(Q61975387)
Statements
A Multicenter Randomized, Double-blind, Placebo Controlled ,Parallel Group ,Phase III Study to Access the Efficacy and Safety of SP2086 Treated Type 2 Diabetes Patients (English)
0 references
December 2012
0 references
January 2014
0 references
450
0 references
18 year
0 references
80 year
0 references